File: Attachment 2026-10-19 EGF Theramed - Press Release - Change of Director.pdf

EGF THERAMED ANNOUNCES APPOINTMENT OF DA COSTA

Vancouver, British Columbia--(October 19, 2026) - EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP) (the "Company" of "EGF") announces it has appointed Kevin Da Costa to the board of directors and as CEO and interim CFO following the resignation of Connor Yuen as a director, CEO, and interim CFO.

Kevin Da Costa is an entrepreneur with extensive experience in business development, digital commerce, technology integration, and brand management, having founded and managed multiple ventures across consumer products, e-commerce, digital services, and emerging technologies. As founder of Vesper Systems, he develops technology-driven business solutions that use artificial intelligence, automation, and data-informed strategies to improve operational performance and uncover new growth opportunities. His hands-on experience and multidisciplinary approach position him to guide EGF Theramed Health Corp. through its next phase of corporate development, as the Company evaluates strategic opportunities, strengthens its operations, explores emerging technologies, and pursues sustainable long-term value for shareholders.

The Company would like to thank Mr. Yuen for his time spent on the Company and wishes him well in his future endeavours.

ABOUT EGF THERAMED HEALTH CORP.

(CSE: TMED) (OTC Pink: EVAHF) (FSE: AUHP)

EGF is a consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs.

For more information please contact:

EGF THERAMED HEALTH CORP.

Connor Yuen Email: connoryuen@conquestvc.com Telephone: 778 999-3353 Website http://www.theramedhealthcorp.com CSE Micro-site: http://thecse.com/en/listings/technology/Theramed-Health-Corporation US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news Frankfurt Borse: http://www.boerse-frankfurt.de/equity/egf-theramed-health-corp-1

CAUTIONARY LANGUAGE

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including with respect to the completion of the Transaction contemplated by the Term Sheet. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.